April 23, 2026 – TheNewswire - Vancouver, British Columbia, Canada - Neurothera Labs Inc. (TSXV: NTLX) (“Neurothera” or the “Company”), a clinical-stage biotech company and a majority-owned subsidiary of SciSparc Ltd. (Nasdaq: SPRC) (“SciSparc”), today announced that it has engaged bullVestor Median GmbH (“bullVestor”) pursuant to an investor relations agreement dated April 23, 2026 for assistance with its investor awareness marketing campaign.

bullVestor provides marketing and investor relations services and will assist the Company in enhancing its visibility with potential investors by providing, among other services, content creation management, keyword optimization, ad groups and display ads, project management, and media distribution for a total cost of euro 300,000 for a 6-month period commencing on or about the date on which the TSX Venture Exchange (“TSXV”) approves the engagement (the “TSXV Approval”). Pursuant to the agreement respecting the engagement, euro 150,000 is payable within seven days following the date of the TSXV Approval, with the remaining euro 150,000 being payable within 45 days following the date of the TSXV Approval. bullVestor is an arm’s length party from the Company and principally operates out of Austria. As of the date of this press release, to the knowledge of the Company, neither bullVestor nor any of its directors and officers own any interest, directly or indirectly, in the securities of the Company. bullVestor’s engagement is subject to approval of the TSXV.

About Neurothera Labs Inc.

Neurothera Labs Inc. (TSXV: NTLX) is a clinical-stage pharmaceutical company focused on developing novel therapeutics for central nervous system disorders and other underserved health conditions through collaborations and innovative combinations.

About bullVestor Medien GmbH

bullVestor Medien GmbH is a company incorporated under the laws of Austria with its registered office at Gutenhofen 4, 4300 St. Valentin, Austria. bullVestor is engaged in the business of providing corporate marketing and investor relations services. bullVestor is wholly-owned by Helmut Pollinger, who serves as its Principal. Neither bullVestor nor its principals have any existing interest, direct or indirect, in the securities of NeuroThera Labs Inc., nor any right or intent to acquire any such interest, other than the compensation payable under the Agreement as described above.

For further information, please contact:

Michal Efraty IR Manager Neurothera Labs Inc.

Telephone: +972-3-7617108

Email: michal@efraty.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward-Looking Information

This press release contains "forward-looking statements" within the meaning of applicable Canadian securities laws. Words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates," "potential," and similar expressions are intended to identify forward-looking statements. Forward-looking statements in this press release include, but are not limited to, statements regarding: the anticipated commencement and duration of bullVestor's investor relations services; the expected timing and amounts of payments to bullVestor; the receipt of TSXV approval of the engagement; and the expected benefits of the investor awareness marketing campaign, including enhanced visibility with potential investors.

Forward-looking statements are based upon management's current expectations and are subject to significant risks and uncertainties that could cause actual results to differ materially, including: the risk that the TSXV may not approve the engagement or may impose conditions on its approval; the risk that the investor awareness campaign may not achieve its intended objectives or enhance the Company's visibility with potential investors; the Company's reliance on SciSparc Ltd. as majority shareholder; the need for substantial additional capital to fund operations and business development activities; general market and economic conditions that may affect investor interest; and other risks inherent in the Company's business. For a more detailed description of risks, reference is made to the Company's filings at sedarplus.ca and, with respect to SciSparc Ltd., filings at sec.gov. This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities. Forward-looking statements speak only as of the date made. The Company assumes no obligation to update forward-looking statements except as required by applicable Canadian securities laws.